Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14

@inproceedings{Rodrguez2012MolecularCO,
  title={Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14},
  author={Ana Eugenia Rodr{\'i}guez and Jos{\'e} {\'A}ngel Hern{\'a}ndez and Roc{\'i}o Benito and Norma Carmen Guti{\'e}rrez and Juan Luis Garcia and Mar{\'i}a Hern{\'a}ndez-S{\'a}nchez and Alberto Risue{\~n}o and Mar{\'i}a Eugenia Sarasquete and Encarna Fermi{\~n}{\'a}n and Rosa Mar{\'i}a Fisac and Alfonso Garc{\'i}a de Coca and Guillermo Mart{\'i}n-N{\'u}{\~n}ez and Natalia de las Heras and Isabel Recio and Oliver Guti{\'e}rrez and Javier De Las Rivas and Marcos Gonzalez and Jes{\'u}s-Mar{\'i}a Hern{\'a}ndez-Rivas},
  booktitle={PloS one},
  year={2012}
}
BACKGROUND Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic… CONTINUE READING